CSIMarket



China Biologic Products Holdings Inc   (CBPO)
Other Ticker:  
 

Cumulative China Biologic Products Holdings Inc 's Quick Ratio for Trailing Twelve Months Period

CBPO's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CBPO Quick Ratio for Trailing Twelve Months Period

(Dec 31 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Current Liabilities Growth -2.48 % -2.48 % -2.48 % -2.48 % 25.31 %
Y / Y Cash & cash equivalent Growth -83.02 % -83.02 % -83.02 % -83.02 % 293.18 %
Quick Ratio for Trailing Twelve Months Period 1.36 2.99 4.61 6.21 7.78
Total Ranking # 1368 # # # # 194
Seq. Current Liabilities Growth 0 % 0 % 0 % -2.48 % 0 %
Seq. Cash & cash equivalent Growth 0 % 0 % 0 % -83.02 % 0 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite year on year decrease in China Biologic Products Holdings Inc 's average Current Liabilities to $119 millions, Quick Ratio for Trailing Twelve Months Period to 1.36 below company average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 125 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than China Biologic Products Holdings Inc . While Quick Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from to 1368.

What is Quick Ratio?
Learn more about CBPO
Quick Ratio CBPO in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 126
Sector # 548
S&P 500 # 1324


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
7.78 2.48 1.25
(Dec 31 2018)   (March 31, 2015)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2019, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Biondvax Pharmaceuticals Ltd   3.73 
Xenetic Biosciences Inc.  3.72 
Cocrystal Pharma Inc.  3.68 
Immunitybio inc.  3.68 
Enzon Pharmaceuticals inc.  3.51 
Atyr Pharma Inc.  3.46 
Microbot Medical Inc  3.40 
Dbv Technologies S.a.  3.40 
Mymd Pharmaceuticals Inc.  3.32 
Cardiff Oncology inc   3.31 
Salarius Pharmaceuticals inc.  3.18 
Frequency Therapeutics Inc.  3.06 
Coherus Biosciences inc.  3.00 
China Biologic Products Holdings Inc   2.99 
Neurocrine Biosciences Inc.  2.99 
Novavax inc.  2.95 
Acorda Therapeutics inc.  2.87 
Kazia Therapeutics Limited  2.86 
Halozyme Therapeutics Inc.  2.86 
Cannapowder Inc   2.81 
Idera Pharmaceuticals Inc.  2.79 
Seagen Inc.  2.67 
Health Discovery Corporation  2.60 
Nanostring Technologies Inc.  2.58 
Cidara Therapeutics Inc.  2.55 
Regenerx Biopharmaceuticals inc.  2.52 
Aclaris Therapeutics Inc.  2.51 
Biofrontera Ag  2.50 
Adma Biologics Inc.  2.49 
Capstone Therapeutics Corp.  2.49 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CIDM's Profile

Stock Price

CIDM's Financials

Business Description

Fundamentals

Charts & Quotes

CIDM's News

Suppliers

CIDM's Competitors

Customers & Markets

Economic Indicators

CIDM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071